-
1
-
-
0033135571
-
A mouse cerberus/Dan-related gene family
-
Pearce JJ, Penny G, Rossant J. A mouse cerberus/Dan-related gene family. Dev Biol. 1999;209(1):98-110.
-
(1999)
Dev Biol
, vol.209
, Issue.1
, pp. 98-110
-
-
Pearce, J.J.1
Penny, G.2
Rossant, J.3
-
2
-
-
33847402760
-
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor
-
DOI 10.1182/blood-2006-06-032276
-
Stabile H, Mitola S, Moroni E, et al. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood. 2007;109(5):1834-1840. (Pubitemid 46348177)
-
(2007)
Blood
, vol.109
, Issue.5
, pp. 1834-1840
-
-
Stabile, H.1
Mitola, S.2
Moroni, E.3
Belleri, M.4
Nicoli, S.5
Coltrini, D.6
Peri, F.7
Pessi, A.8
Orsatti, L.9
Talamo, F.10
Castronovo, V.11
Waltregny, D.12
Cotelli, F.13
Ribatti, D.14
Presta, M.15
-
3
-
-
51649116092
-
Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm
-
Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M. Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm. Blood. 2008;112(4):1154-1157.
-
(2008)
Blood
, vol.112
, Issue.4
, pp. 1154-1157
-
-
Mitola, S.1
Moroni, E.2
Ravelli, C.3
Andres, G.4
Belleri, M.5
Presta, M.6
-
4
-
-
33646565011
-
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein
-
Namkoong H, Shin SM, Kim HK, et al. The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer. 2006;6:74.
-
(2006)
BMC Cancer
, vol.6
, pp. 74
-
-
Namkoong, H.1
Shin, S.M.2
Kim, H.K.3
-
5
-
-
33749528535
-
Bone morphogenetic protein antagonist gremlin 1 is wideley expressed by cancer-associated stromal cells and can promote tumor cell proliferation
-
DOI 10.1073/pnas.0606857103
-
Sneddon JB, Zhen HH, Montgomery K, et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A. 2006;103(40):14842-14847. (Pubitemid 44527816)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.40
, pp. 14842-14847
-
-
Sneddon, J.B.1
Zhen, H.H.2
Montgomery, K.3
Van De Rijn, M.4
Tward, A.D.5
West, R.6
Gladstone, H.7
Chang, H.Y.8
Morganroth, G.S.9
Oro, A.E.10
Brown, P.O.11
-
6
-
-
33646107369
-
VEGF receptor signalling - In control of vascular function
-
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359-371.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, Issue.5
, pp. 359-371
-
-
Olsson, A.K.1
Dimberg, A.2
Kreuger, J.3
Claesson-Welsh, L.4
-
7
-
-
0035010433
-
Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules
-
Vitt UA, Hsu SY, Hsueh AJ. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol. 2001;15(5):681-694.
-
(2001)
Mol Endocrinol
, vol.15
, Issue.5
, pp. 681-694
-
-
Vitt, U.A.1
Hsu, S.Y.2
Hsueh, A.J.3
-
8
-
-
0032893263
-
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
-
Fong TA, Shawver LK, Sun L, et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 1999;59(1):99-106.
-
(1999)
Cancer Res
, vol.59
, Issue.1
, pp. 99-106
-
-
Fong, T.A.1
Shawver, L.K.2
Sun, L.3
-
9
-
-
33746936677
-
Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells
-
Ewan LC, Jopling HM, Jia H, et al. Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic. 2006;7(9):1270-1282.
-
(2006)
Traffic
, vol.7
, Issue.9
, pp. 1270-1282
-
-
Ewan, L.C.1
Jopling, H.M.2
Jia, H.3
-
10
-
-
0029929716
-
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
-
Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996;271(30):17629-17634.
-
(1996)
J Biol Chem
, vol.271
, Issue.30
, pp. 17629-17634
-
-
Clauss, M.1
Weich, H.2
Breier, G.3
-
11
-
-
0042817965
-
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor
-
Zilberberg L, Shinkaruk S, Lequin O, et al. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem. 2003;278(37):35564-35573.
-
(2003)
J Biol Chem
, vol.278
, Issue.37
, pp. 35564-35573
-
-
Zilberberg, L.1
Shinkaruk, S.2
Lequin, O.3
-
12
-
-
0032474915
-
Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases
-
DOI 10.1021/jm980123i
-
Sun L, Tran N, Tang F, et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem. 1998;41(14):2588-2603. (Pubitemid 28321908)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.14
, pp. 2588-2603
-
-
Sun, L.1
Tran, N.2
Tang, F.3
App, H.4
Hirth, P.5
McMahon, G.6
Tang, C.7
-
13
-
-
0037743636
-
Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning
-
DOI 10.1038/ng1178
-
Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM. Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet. 2003;34(3):303-307. (Pubitemid 36792863)
-
(2003)
Nature Genetics
, vol.34
, Issue.3
, pp. 303-307
-
-
Khokha, M.K.1
Hsu, D.2
Brunet, L.J.3
Dionne, M.S.4
Harland, R.M.5
-
14
-
-
0036385254
-
Gremlin: An example of the re-emergence of developmental programmes in diabetic nephropathy
-
Lappin DW, McMahon R, Murphy M, Brady HR. Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant. 2002;17(suppl 9):65-67.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.SUPPL. 9
, pp. 65-67
-
-
Lappin, D.W.1
McMahon, R.2
Murphy, M.3
Brady, H.R.4
-
15
-
-
0036346678
-
Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation
-
Chen B, Athanasiou M, Gu Q, Blair DG. Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation. Biochem Biophys Res Commun. 2002;295(5):1135-1141.
-
(2002)
Biochem Biophys Res Commun
, vol.295
, Issue.5
, pp. 1135-1141
-
-
Chen, B.1
Athanasiou, M.2
Gu, Q.3
Blair, D.G.4
-
16
-
-
12344274486
-
The biology of vascular endothelial growth factors
-
DOI 10.1016/j.cardiores.2004.12.002, PII S0008636304005498
-
Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65(3):550-563. (Pubitemid 40138976)
-
(2005)
Cardiovascular Research
, vol.65
, Issue.3
, pp. 550-563
-
-
Tammela, T.1
Enholm, B.2
Alitalo, K.3
Paavonen, K.4
|